HHealthcare Read More Vertex kidney drug povetacicept succeeds in trial for IgANMarch 10, 2026 A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters…
HHealthcare Read More Baxter International Inc. (BAX): A Bull Case TheoryAugust 9, 2025 We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will summarize…
HHealthcare Read More Are Wall Street Analysts Bullish on Baxter International Stock?August 6, 2025 Valued at a market cap of $11.3 billion, Baxter International Inc. (BAX) is a global healthcare and medtech company…